MAP2K7 and breast cancer: Both basal and ligand-induced migration and invasiveness of ER-α36 expressing breast cancer cells were drastically reduced after treatment of MEK inhibitor U0126.These results implicated that phosphorylation of ERK1/2 by MEK might be involved in the cell motility and invasiveness.